| Clinical vaccine development S Han Clinical and experimental vaccine research 4 (1), 46, 2015 | 135 | 2015 |
| Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients SH Kim, DS Yim, SM Choi, JC Kwon, S Han, DG Lee, C Park, EY Kwon, ... International Journal of Infectious Diseases 15 (11), e753-e758, 2011 | 83 | 2011 |
| Population pharmacokinetics of meropenem in burn patients K Doh, H Woo, J Hur, H Yim, J Kim, H Chae, S Han, DS Yim Journal of antimicrobial chemotherapy 65 (11), 2428-2435, 2010 | 69 | 2010 |
| A population pharmacokinetic–pharmacodynamic model for simvastatin that predicts low‐density lipoprotein‐cholesterol reduction in patients with primary hyperlipidaemia J Kim, BJ Ahn, HS Chae, S Han, K Doh, J Choi, YK Jun, YW Lee, DS Yim Basic & clinical pharmacology & toxicology 109 (3), 156-163, 2011 | 51 | 2011 |
| Population pharmacokinetic analysis of colistin in burn patients J Lee, S Han, S Jeon, T Hong, W Song, H Woo, DS Yim Antimicrobial agents and chemotherapy 57 (5), 2141-2146, 2013 | 39 | 2013 |
| Model-based adaptive phase I trial design of post-transplant decitabine maintenance in myelodysplastic syndrome S Han, YJ Kim, J Lee, S Jeon, T Hong, G Park, JH Yoon, SA Yahng, ... Journal of Hematology & Oncology 8, 1-9, 2015 | 34 | 2015 |
| Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β‐cyclodextrin in haematological patients with renal impairment SH Kim, JC Kwon, C Park, S Han, DS Yim, JK Choi, SY Cho, HJ Lee, ... Mycoses 59 (10), 644-651, 2016 | 33 | 2016 |
| Population pharmacokinetic analysis of piperacillin in burn patients S Jeon, S Han, J Lee, T Hong, J Paek, H Woo, DS Yim Antimicrobial agents and chemotherapy 58 (7), 3744-3751, 2014 | 32 | 2014 |
| Population pharmacokinetic analysis of fluconazole to predict therapeutic outcome in burn patients with Candida infection S Han, J Kim, H Yim, J Hur, W Song, J Lee, S Jeon, T Hong, H Woo, ... Antimicrobial agents and chemotherapy 57 (2), 1006-1011, 2013 | 25 | 2013 |
| Application of pharmacometrics in pharmacotherapy: Open-source software for vancomycin therapeutic drug management SH Bae, DS Yim, H Lee, AR Park, JE Kwon, H Sumiko, S Han Pharmaceutics 11 (5), 224, 2019 | 22 | 2019 |
| A randomized, double-blind trial comparing the pharmacokinetics of CT-P16, a candidate bevacizumab biosimilar, with its reference product in healthy adult males SH Cho, S Han, JL Ghim, MS Nam, S Yu, T Park, S Kim, J Bae, JG Shin BioDrugs 33, 173-181, 2019 | 18 | 2019 |
| The safety and pharmacokinetics of cyanidin-3-glucoside after 2-week administration of black bean seed coat extract in healthy subjects S Jeon, S Han, J Lee, T Hong, DS Yim The Korean Journal of Physiology & Pharmacology: Official Journal of the …, 2012 | 17 | 2012 |
| Pharmacokinetic–pharmacodynamic model of fimasartan applied to predict the influence of a high fat diet on its blood pressure-lowering effect in healthy subjects J Lee, S Han, S Jeon, T Hong, DS Yim European journal of clinical pharmacology 69, 11-20, 2013 | 16 | 2013 |
| Population pharmacokinetic/pharmacodynamic modeling of clopidogrel in Korean healthy volunteers and stroke patients J Lee, Y Hwang, W Kang, SJ Seong, M Lim, HW Lee, DS Yim, DR Sohn, ... The Journal of Clinical Pharmacology 52 (7), 985-995, 2012 | 16 | 2012 |
| Pharmacokinetic-pharmacodynamic analysis to evaluate the effect of moxifloxacin on QT interval prolongation in healthy Korean male subjects T Hong, S Han, J Lee, S Jeon, GJ Park, WS Park, KS Lim, JY Chung, ... Drug Design, Development and Therapy, 1233-1245, 2015 | 15 | 2015 |
| Pre-transplant depression decreased overall survival of patients receiving allogeneic hematopoietic stem cell transplantation: a nationwide cohort study SM Wang, SS Park, SH Park, NY Kim, DW Kang, HR Na, JW Lee, S Han, ... Scientific Reports 10 (1), 15265, 2020 | 14 | 2020 |
| Association between dementia and clinical outcome after COVID-19: a nationwide cohort study with propensity score matched control in South Korea SM Wang, SH Park, NY Kim, DW Kang, HR Na, YH Um, S Han, SS Park, ... Psychiatry Investigation 18 (6), 523, 2021 | 13 | 2021 |
| Bortezomib pharmacokinetics in tumor response and peripheral neuropathy in multiple myeloma patients receiving bortezomib-containing therapy SE Lee, K Choi, S Han, J Lee, T Hong, GJ Park, DS Yim, CK Min Anti-Cancer Drugs 28 (6), 660-668, 2017 | 13 | 2017 |
| Drug–drug interaction of microdose and regular-dose omeprazole with a CYP2C19 inhibitor and inducer G Park, SH Bae, WS Park, S Han, MH Park, SH Shin, YG Shin, DS Yim Drug Design, Development and Therapy, 1043-1053, 2017 | 13 | 2017 |
| Use of a Target‐Mediated Drug Disposition Model to Predict the Human Pharmacokinetics and Target Occupancy of GC 1118, an Anti‐epidermal Growth Factor Receptor Antibody WS Park, S Han, J Lee, T Hong, J Won, Y Lim, K Lee, HY Byun, DS Yim Basic & clinical pharmacology & toxicology 120 (3), 243-249, 2017 | 13 | 2017 |
